Skip to main content
Genomictree Inc. logo

Genomictree Inc. — Investor Relations & Filings

Ticker · 228760 ISIN · KR7228760005 KO Professional, scientific and technical activities
Open in API
Filings indexed 237 across all filing types
Latest filing 2022-06-17 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 228760

About Genomictree Inc.

https://genomictree.com/eng/

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Recent filings

Filing Released Lang Actions
기타경영사항(자율공시)(전환우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Genomictree regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the filing definitions, announcements regarding new share issues or capital changes (including conversions that result in new common shares) fall under the 'Share Issue/Capital Change' (SHA) category.
2022-06-17 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a corporate action involving the company buying back its own shares through a trust, which falls under the category of 'Transaction in Own Shares'.
2022-05-17 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Genomictree (지노믹트리) covering the period from January 1, 2022, to March 31, 2022. It contains detailed corporate information, capital structure, and management details, which is characteristic of a formal quarterly financial filing submitted to the Financial Services Commission and the Korea Exchange. This fits the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-12 Korean
전환가액의조정(제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of convertible shares, and the underlying methodology based on market price fluctuations. This type of disclosure relates to capital structure changes and financing instruments, which falls under the 'Capital/Financing Update' category.
2022-05-02 Korean
기타경영사항(자율공시)(전환우선주 전환가액 조정)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price of convertible preferred shares due to a decline in market price. This type of disclosure relates to changes in capital structure and potential share dilution, which falls under the category of 'Share Issue/Capital Change' (SHA) as it directly impacts the company's equity instruments and conversion terms.
2022-05-02 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it is a regulatory disclosure of an IR activity, it fits best under the 'Regulatory Filings' (RNS) category as it is a standard corporate disclosure of an event schedule.
2022-04-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.